Bill C-37 (Historical)

An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts

This enactment amends the Controlled Drugs and Substances Act to, among other things,
(a) simplify the process of applying for an exemption that would allow certain activities to take place at a supervised consumption site, as well as the process of applying for subsequent exemptions;
(b) prohibit the importation of designated devices — unless the importation is registered with the Minister of Health — as well as prescribed activities in relation to designated devices;
(c) expand the offence of possession, production, sale or importation of anything knowing that it will be used to produce or traffic in methamphetamine so that it applies to anything that is intended to be used to produce or traffic in any controlled substance;
(d) authorize the Minister to temporarily add to a schedule to that Act substances that the Minister has reasonable grounds to believe pose a significant risk to public health or safety, in order to control them;
(e) authorize the Minister to require a person who may conduct activities in relation to controlled substances, precursors or designated devices to provide the Minister with information or to take certain measures in respect of such activities;
(f) add an administrative monetary penalties scheme;
(g) streamline the disposition of seized, found or otherwise acquired controlled substances, precursors and chemical and non-chemical offence-related property;
(h) modernize inspection powers; and
(i) expand and amend certain regulation-making authorities, including in respect of the collection, use, retention, disclosure and disposal of information.
It makes related amendments to the Customs Act and the Proceeds of Crime (Money Laundering) and Terrorist Financing Act to repeal provisions that prevent customs officers from opening mail that weighs 30 grams or less.
It also makes other related amendments to the Criminal Code and the Seized Property Management Act.

Controlled Drugs and Substances Act

[Colin Carrie, Conservative, Oshawa, ON]

Mr. Speaker, today we are debating a motion put forward by the Minister of Health. The motion addresses the amendments proposed by the Senate in regard to Bill C-37, an act to amend the Controlled Drugs and Substances Act and to make related amendments to other acts.

First, I want to stress that the opioid crisis continues to be an absolute tragedy. People across the country are still dying at an alarming rate, and there is no one solution to this. In fact, I think most Canadians would agree that there are many factors that have contributed to and continue to contribute to this serious issue.

When Bill C-37 was first introduced in the House, I made a point to let the minister know that my colleagues and I were very much in favour of the majority of the bill. I had the chance to take part in a health committee study that had taken place prior to the tabling of the bill which looked specifically at the opioid crisis in our country and what we were facing.

Taking part in the study allowed me to truly learn and empathize with struggling addicts, communities, first nations, health professionals, and families that have had to endure an opioid-related death. We learned that there were many factors that contributed to this crisis. While one cause of the crisis results from illegal substances and organized crime, many people are battling addiction because of the practice of over-prescribing of painkillers. Some of these causes have yet to be addressed, but I definitely think the right steps are being taken, at least for the most part.

I stated earlier that I was in favour of most of the bill, and that is because the minister recognized that tackling the production, distribution, importation, and consumption of deadly drugs needs to be made a priority. She listened to the advice of Conservatives on the health committee and in the Senate, and I commend her for that. I will not get into details about Bill C-37 as I have already had the opportunity to do so twice now, but I do think it is important to acknowledge and point to the bill's attempt to weaken public consultation in the approval of injection sites.

That is why, when I had the chance to review the Senate's amendments to Bill C-37, I was glad to put my support behind them. I will summarize the Senate's amendments.

The first amendment ensures that there is a minimum consultation period of 45 days prior to the approval of an injection site. The second amendment looks to establish a citizen advisory committee responsible for advising the approved injection site of any public concerns, including public health and safety. The amendment also looked to have the committee provide the minister with a yearly update on these matters. The third amendment directs those working at the site to offer the person using the site legal pharmaceutical therapy before that person consumes illegal drugs obtained illegally.

Unlike here in the House where the Liberals rammed the bill through with minimal debate, the Standing Senate Committee on Legal and Constitutional Affairs was able to hold five meetings and hear from 22 witnesses. That is in contrast to the health committee, which only scheduled one meeting on the bill, with only four witnesses appearing, and none of whom was the Minister of Health.

The Senate's amendments are well thought out and take into consideration communities and those battling addiction. I must admit that I was surprised to see the minister agree to the first amendment, as her colleagues voted against the same amendment brought forward by the Conservatives. I am happy that she made the right choice in ensuring that communities at least will have some chance to be involved, if only in a small way.

I do, however, want to acknowledge my disappointment with her rejection of a voluntary community committee. The minister's refusal to include community involvement in regard to injection sites goes against the majority of testimony we heard. Over and over again, witnesses at committee stated that injection sites would not be successful without community support. Community support goes beyond harm reduction advocates. It includes mothers, fathers, law enforcement, and of course the local government. The minister knows that by passing the Senate's amendment to establish a citizen advisory committee, it would demonstrate and respect the fact that not everyone wants an injection site in his or her backyard.

I want to talk about the reasons I support a community committee. By establishing a community committee, it would ensure that the injection site remains clean, and that it operates in a way that prioritizes the health and safety of Canadians. It would ensure that the minister of health, the individual who is responsible and who ultimately approves the site, remains in the loop about the community's concerns with regard to the site. It would ensure that he or she, along with the actual operators of the site, would be held accountable and to a high standard. That should be the goal. The health and safety of those battling addiction and the health and safety of all citizens should be a priority.

That is why I was shocked that the minister's motion looks to change the wording of the Senate amendment that would improve the bill. The third amendment seeks to offer pharmaceutical therapy as a substitution to an illegally obtained and possibly deadly poison. I realize that the minister's concerns lay in the fact that these sites may range in different services such as an injection site within a hospital to mobile injection sites, but what strikes me as odd is that we would discourage the use of a legal substitution for heroin such as methadone.

For those who may not know, methadone is a maintenance treatment which, according to the Centre for Addiction and Mental Health, CAMH, prevents opioid withdrawal and reduces or eliminates drug cravings. It is by offering substitutions that are legal and of pharmaceutical grade such as methadone that could lead a serious drug dependent individual to seek treatment and get the help he or she needs to get clean. Again, should that not be the goal?

The CAMH also states that an individual who is physically dependent on opioids such as heroin or fentanyl is kept free of withdrawal symptoms for 24 hours after a single dose of methadone. In contrast, a person who uses heroin or other short-acting opioids must use three or four times a day to avoid withdrawal. There is no argument here. By ensuring that users are offered legal substitution, crime rates will decrease and the likelihood of seeking detoxification treatment will go up.

I would like to read testimony from the Senate's hearing in which the minister was actually a witness.

I will quote Senator White:

I spent last Sunday night and Monday night in East Hastings with police officers and health officials walking up and down those streets and visiting some of the facilities. The biggest concern raised by community members who aren't addicts and by police officers and health officials is the use of illegal drugs.

I notice that we did see a regulatory change that will allow for the use of medical-grade heroin, but we did not see any regulatory changes that will allow for the medical use of other than medical-grade heroin.

My perspective and that of most people around supervised injection sites is that they move to the relationship between a doctor and an addict, not organized crime, a drug dealer and an addict who is committing crimes but an addict and the doctor which is where it is now. Will we see regulatory change that will allow for greater use of prescriptive pharmaceuticals rather than illegal and illicit poison? I don't want to call them drugs because they're not that.

At that time, the Minister of Health responded. She said:

Thank you for the question. It is a very good one. I encourage honourable senators to work with us in ensuring that access to all range of treatments and responses to this health problem are there. Some of this requires the decisions of provinces and territories as well as medical practitioners who obviously make decisions about what appropriate treatments are.

There is nothing in the bill and nothing in the law that would prevent provinces from expanding a treatment centre associated with a supervised consumption site to be able to allow these kind of treatments to which you are referring to work closely. I think it is an outstanding model and it's a model that we have to perhaps talk about a little more in public.

I know, senator, you are well aware of the work done in other countries. Switzerland is perhaps the best example of that. When people are determined to have opioids use disorder and/or have legal problems associated with their substance use disorder they are introduced to the possibility of being able to be prescribed medications. It certainly has been effective in decreasing crime rates in those areas, very dramatically decreasing overdose rates and treating this as a health issue.

That is what the minister said when she was a witness. Why the change? In Switzerland, they do in fact offer drug substitution as proposed in the Senate amendment, and as stated, it has led to a dramatic reduction of illegal drugs, has reduced crime rates, and has lowered overdose rates. This model has seen high levels of acceptance because rather than an addict illegally obtaining illegal drugs, the individual is able to get pharmacological help from a doctor with the goal of leading to seeking proper treatment. That is why this is so important.

This amendment would allow an individual to enter a site and be offered a legal drug by a medical practitioner as opposed to a dangerous and potentially deadly drug, a poison bought from a drug dealer. This, as I have stated, removes the potential of overdosing and eliminates criminal activity. If the Liberals really wanted to treat addiction as a health problem, they should be encouraging doctors and nurses to be at these sites administering alternatives that many addicts do not even know about.

We should not be encouraging irresponsible administering of illegal drugs that are manufactured and mixed in a drug dealer's basement lab. We know that they are being laced with fentanyl, carfentanil, and much more. We have an overdose crisis in this country. I will not object to the assertion that injection sites can temporarily save lives, as it is always better when an individual is revived, but we need to be looking at ways to prevent the overdose from happening in the first place.

I believe this amendment that would guarantee that the drug user is offered an alternative pharmaceutical therapy prior to putting something poisonous and potentially deadly into his or her body would do just that. That is why it is crucial that the Liberal government take initiative and ensure that injection sites do not become a place for people simply to get high. If injection sites are wanted in communities, they should be used to ensure that addicts are offered legal, safer alternatives to dangerous and illegal street drugs that have been obtained illegally from drug dealers, alternatives that would decrease overdose rates and decrease crime rates, which I believe should be the overall goal.

I realize that the minister has not flat-out rejected the amendment, but by changing the words “shall offer” to “may offer”, we would guarantee that the majority of users would not be offered a legal, safer alternative. We would not force diabetic Canadians who rely on insulin to commit a crime or numerous crimes to find an illegal insulin supply and to buy their treatment from drug dealers, would we?

Canadians expect their government, if it truly feels that addiction should be treated as a health problem, to provide safe treatment options and detoxification programs for those suffering from addiction. The Liberal plan, unfortunately, provides none of that. The response to this crisis has been horribly slow. We are still debating a bill that was tabled in December and communities are still seeing an increase in overdose deaths. Our country has seen no progress in increasing access to detox treatment, which is another issue that must be addressed but has failed to be addressed by the current Liberal government. We know that not all addicts are willing to go into treatment, which is why I believe that, with the certainty of many new injection sites opening up in the near future, we should at a bare minimum be ensuring that users have a choice between a poisonous street drug or a legal alternative.

In conclusion, this is how I view the situation. The motion put forth by the minister leaves out communities and eliminates the likelihood of reducing crime and overdose rates by offering legal substitution. The approval of an injection site will have a profound impact on any community. Perhaps some will be successful and some will not, but the individual approving the site, the minister of health, should be putting the health of Canadians first. He or she should be encouraging the use of pharmaceutical alternatives over illegally obtained street poison. He or she should be held accountable for the success or failure of approved sites, and not just be the individual responsible for rubber-stamping them. The minister has not even stated how she will measure that success. Will she keep statistics on how many addicts get referred to treatment and on how many are referred to detox programs?

This is why I would encourage all parties and members of this House to review very carefully the Senate amendments. They would not make the application process any more difficult and they would not slow down the approval process. All they would do is give citizens within a community that has an approved site a voice, and give those who are addicted to deadly drugs a safer alternative. In a caring country such as ours, should that not be what it is all about?

The Senate amendments were well thought out and put the health and safety of Canadians first. I challenge the Liberals to do the same. Therefore, I move:

That the motion be amended by deleting all the words after the word “That” and substituting the following: “the amendments made by the Senate to Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts, be now read a second time and concurred in.”

[Joël Lightbound, Liberal, Louis-Hébert, QC]

Mr. Speaker, I thank the hon. NDP member for the question and the entire NDP party for its response to the opioid crisis and all its work in committee and in the House of Commons on Bill C-37. We know that this bill will save lives. It probably should have been introduced sooner, by the previous government perhaps, but so be it.

As far as the member's question on the amendment is concerned, it should be noted that this amendment requires a 45-day minimum consultation, if necessary. Not every request is subject to a 45-day minimum consultation. In cases where this is necessary, where there might be a need for community consultation, there would be a consultation period of no less than 45 days and no more than 90 days. In these cases, we think it is only right to give the public time to be heard.

As I said in my speech, this will only happen if there is a need for such consultation. It will be determined on a case-by-case basis.

[Joël Lightbound, Liberal, Louis-Hébert, QC]

Mr. Speaker, as the member pointed out when he talked about how we got here, one of the reasons we got to Bill C-37 is that initially, the Conservatives' Bill C-2 established 26 criteria, which were very burdensome for communities that need and want safe consumption sites, which science demonstrates save lives.

Our idea was to come back to the five criteria established by the Supreme Court and to get closer to those criteria so we could move more swiftly, because we know that every single day Canadians are dying from opioid use in this country. We need to take swift action and act decisively, with respect for the communities where they would be established. We need to make sure that where they are needed and wanted, these safe consumption sites are established.

[Joël Lightbound, Liberal, Parliamentary Secretary to the Minister of Health]

Mr. Speaker, I am very pleased to rise in the House of Commons today to speak in support of Bill C-37, an act to amend the Controlled Drugs and Substances Act and to make related amendments to other acts and to discuss the amendments adopted by the Senate. This is an important bill, as all members know, a bill that will save lives.

First, I would like to thank the Senate, the House of Commons Standing Committee on Health, and the Standing Senate Committee on Legal and Constitutional Affairs for their swift but thorough consideration of Bill C-37.

It is clear from the discussions and debates that have taken place that, while we may not always agree on a way forward, we all understand the urgency of the situation and share the same goal of saving lives and reducing the growing number of opioid overdoses.

The Senate has adopted three amendments to Bill C-37, all of which deal with the proposed application process and requirements to obtain an exemption under the Controlled Drugs and Substances Act for a supervised consumption site.

The first amendment adopted by the Senate modifies the ministerial authority to post a public notice and solicit input concerning a specific application.

The version of Bill C-37 adopted by the House of Commons proposed allowing the minister to determine an appropriate length of time for public comment, up to a maximum of 90 days. The amendment adopted in the Senate requires that any consultation must be a minimum of 45 days, and retains the previous maximum of 90 days. Our government supports this amendment.

I understand that there have been some questions from public health stakeholders on whether setting a minimum consultation period could delay applications. I want to reiterate that this consultation period is not required, but rather that a public notice can be posted, if there is a need. Such an authority would likely be used if there were concerns that community consultations were not sufficient. Further input would be helpful in making a decision in such instances, ensuring a reasonable amount of time is provided to the public to comment on a specific application. We think it makes sense. Therefore, we support this amendment.

The second amendment adopted by the Senate specifies that the Minister of Health may establish citizen advisory committees for approved supervised consumption sites where it is deemed appropriate.

While such committees could be seen as a way to maintain an open and ongoing dialogue with the surrounding community, it also represents a level of citizen oversight and influence that is not in place for any other health care service. We know that people who use drugs already face discrimination and stigmatization that can prevent them from accessing the services they need to stay alive. By including a process that could further add to the stigmatization faced by people who use drugs, this amendment runs against the intent and the spirit of Bill C-37. For this reason, our government respectfully disagrees with the second amendment.

Finally, the last amendment adopted by the Senate would require staff who supervise the consumption of substances at a site to offer clients access to an alternative pharmaceutical therapy before they consume illegal drugs at a supervised consumption site.

I would like to explain some of the concerns that our government has with this amendment as it is currently written. I want to make it very clear that our government is entirely supportive of providing immediate access to evidence-based treatment options for people living with addictions who are ready and willing to enter treatment. This would be the ideal situation. However, the situation in practice at a supervised consumption site is far more complex than simply writing the words into legislation. There are a number of factors that must be considered.

First, as I have already mentioned, people who use drugs already face significant barriers in accessing the health and social services they need, often due to stigmatization and discrimination. Supervised consumption sites are meant to be low-threshold, easily-accessible services. The more requirements or rules that are added to the process for accessing supervised consumption sites, the less accessible this service becomes to the vulnerable population it is meant to serve. Further, if this amendment is included in the legislation, I want to make it clear that none of the supervised consumption sites operating in Canada, nor most of the 18 applications that are currently before Health Canada for consideration, would meet the legislated criteria for operation. If the single word “shall” is kept in the amendment, additional requirements and burdens are automatically imposed upon supervised consumption sites and those who operate them.

This would make it more difficult to establish new supervised consumption sites in communities where they are wanted and needed. As such, requiring staff to offer immediate access to treatment could cause significant delays in the opening of any new supervised consumption sites. The purpose of Bill C-37 is to reduce burden and streamline the application process so that communities can open supervised consumption sites as part of a comprehensive plan to reduce harms associated with illegal drug use, including deaths. Given the current opioid crisis, these considerations raise major concerns for our government.

Finally, except in certain specific circumstances, regulating health care services is generally the responsibility of the provinces and territories. Our government has taken concrete action to pave a path forward towards improving treatment, for example, by removing barriers at the federal level and undertaking knowledge-exchange activities to improve awareness of the options available in Canada. However, at the end of the day, the provinces must make health care decisions based on the needs of their citizens. There are also costs associated with offering access to immediate treatment. This is something that would have to be considered by the provinces and weighted against their other health priorities.

The fact is that Canadians are dying every single day, and communities are urging us to set up supervised consumption sites to stop the overdoses and the deaths. I do not want the federal government to be what stands in the way of communities saving lives here and now. Improving access to treatment is a goal that our government will continue to support. I can assure the House that our government will continue to support future supervised consumption sites in developing a strong link with treatment services. We will encourage all potential sites to work closely with their respective provincial governments to make this happen. However, for the reasons I have just outlined, our government submits that the word “shall” in this provision must be changed to the word “may”.

By now, everyone in this room is well aware of the critical and urgent nature of the opioid crisis that has been devastating communities across the country. The rising mortality rates and drug overdoses are deeply concerning. These are real communities where real people are dying, communities where front-line workers are exhausted, and friends and families are losing loved ones. We are facing a public health crisis, and we need to work together to stop it from claiming more lives. In order to do so, our actions must be collective, comprehensive, and aimed directly at protecting the health and safety of our communities. This is a complex issue that requires a comprehensive approach.

The Minister of Health has been clear that Canada’s drug policy must be comprehensive, compassionate, collaborative, and evidence-based, and use a public health approach when considering and addressing drug issues.

To that end, on December 12, 2016, the Minister of Health announced an updated drug strategy for Canada. The Canadian drugs and substances strategy would replace the current national anti-drug strategy. This strategy formally restores harm reduction as a core pillar of Canada's drug policy, alongside prevention, treatment, and enforcement. All pillars are supported by a strong evidence base. The minister further supported this approach when she introduced Bill C-37, a bill that proposes many important legislative changes to address the opioid crisis. Problematic opioid use involves an intricate web of intersecting issues that must be addressed simultaneously, using different tactics.

Today I would like to underline the importance of continuing to move quickly through the legislative process.

First, the proposed changes contained in the bill would provide the law enforcement community with the tools needed to better address the supply of illicit opioids and other drugs in Canada and to reduce the risk of the diversion of controlled substances. The sharp rise in opioid-related overdoses and deaths has been intensified by an increase in illicit fentanyl coming into Canada. Bill C-37 would ensure that law enforcement is better equipped to keep deadly drugs like illicit fentanyl out of our communities, in a number of ways, such as making it a crime to possess or transport anything intended to be used to produce or traffic a controlled substance, allowing temporary scheduling of new psychoactive substances, and supporting faster and safer disposal of seized chemicals and other dangerous substances.

It is critical that we support members of the law enforcement community who work on the front lines of the opioid crisis. It is critical that this bill be passed quickly so we can prevent illicit opioids and other drugs from reaching our communities.

Our government is also committed to working with its partners to help reduce the harm to citizens and communities associated with problematic substance use. Evidence has shown that supervised consumption sites, when properly established and maintained, have the potential to save lives and improve health without increasing drug use and crime in the surrounding area. Bill C-37 proposes to support communities seeking to operate supervised consumption sites by streamlining the application process, as well as the renewal process for existing sites, to align with the five factors set out by the Supreme Court of Canada, without compromising the health and safety of the surrounding community.

A key component of this legislation involves ensuring that the voices of communities are heard by being more flexible and supporting the ability to tailor consultations to each community as appropriate. This improved approach preserves the requirements for community engagement. Each application would be subject to a comprehensive review, without delaying the implementation of these life-saving sites in the communities that need them the most.

We all have an important role to play in overcoming this crisis. We must support the efforts of all community members, from the volunteers, civil society organizations, health professionals, legal professionals, and of course law enforcement groups, if we are going to tackle this crisis.

The legislative changes proposed in Bill C-37 demonstrate our government's concrete support for communities grappling with this crisis by increasing law enforcement's ability to respond to the evolution of the illicit drug market and to take early action against suspected drug production operations. Furthermore, the changes proposed in the bill to remove unnecessary barriers to establishing supervised consumption sites and to emphasize community engagement would support communities by ensuring that these sites ultimately met the objectives of saving lives and reducing harm.

Our government will continue to work collaboratively with communities, provinces, territories, and key stakeholders through a comprehensive approach to drug policy.

I want to thank every one of you for your work on Bill C-37 and for your commitment to this urgent matter. We cannot turn our backs on the communities being affected by this crisis across the country.

I urge all members of the House to move forward with the proposed legislative changes, which would support communities, and ultimately, save lives.

[Ted Falk, Conservative, Provencher, MB]

Thank you, Minister, for coming to the committee.

I was recently watching a panel discussion in which you and the Minister of Health were discussing the proposed marijuana legislation. I forget who the host was. Of particular interest to me was a comment you made, that you had not ever been a cannabis user, nor did you expect to be after this legislation was passed.

I have two questions for you.

First, why is it not a good thing for you, but it's okay for others—even for the youth of our society—to have access to cannabis as a recreational drug? I commend you for your personal position.

Second, I'm looking at the legislation your government has presented so far in the last year and a half, which you say you're very proud of. Bill C-14, the medical assistance in dying legislation, now allows Canadians to legally have their lives terminated with the assistance of a physician. Bill C-16 addresses what I think is an imaginary gap in both our Canadian Human Rights Act and our Criminal Code. Bill C-32 repeals section 159 of the Criminal Code, which addresses anal sex. Bill C-37, which repeals the Respect for Communities Act, will now make it easier for safe injection sites to be located in different communities across Canada. The most recent one, Bill C-45, is of course on the legalization of marijuana.

My question on all those issues is, I think, quite simple. These pieces of legislation seem to have a particular theme to them. I'm wondering what it is that motivates your government to, in my opinion, be so bent on and recklessly determined to destroy our social and moral fabric?

Business of the House

[Kevin Lamoureux, Liberal, Parliamentary Secretary to the Leader of the Government in the House of Commons]

Mr. Speaker, this afternoon we will continue with the debate on the NDP opposition motion. Tomorrow morning the House will begin consideration of Senate amendments to Bill C-37, the opioids legislation. Following question period, we will proceed to Bill C-7, the RCMP labour bill.

On Monday and Tuesday next week, we will return to debate on the bills just listed. On Wednesday we will resume debate on Bill C-4, respecting unions. In the evening, the House will consider the estimates for the Department of Foreign Affairs, Trade and Development in committee of the whole.

Next Thursday, May 18, shall be an allocated day.

Controlled Drugs and Substances Act

[Kevin Lamoureux, Liberal, Parliamentary Secretary to the Leader of the Government in the House of Commons]

Mr. Speaker, the opioid crisis in Canada is something that the government has recognized. The Minister of Health has done a phenomenal job working with the many stakeholders, particularly the Province of British Columbia, not only recognizing the problem but taking actions that will ultimately assist in resolving the problem the best way we can.

The member and others are aware of Bill C-37, a bill introduced by the Minister of Health, which addresses the opioid crisis. However, that is not all this government has done. The government has also provided an additional $65 million over five years for national measures to respond to the opioid crisis and implemented an opioid action plan. In addition, the government has provided $10 million in urgent support for British Columbia, to assist with its response to the overwhelming effects of the emergency in that province. We recognize that this issue goes well beyond the province of British Columbia. The government is seized with the issue and will continue to move forward.

With respect to the issues the member has brought forward in this legislation, the parliamentary secretary said it best, that measures are already in place in Canada. Quite often, the courts will exceed the three years.

[Cathy McLeod, Conservative, Kamloops—Thompson—Cariboo, BC]

Mr. Speaker, I am very pleased stand to congratulate my colleague from Markham—Unionville on this very important private member's bill, Bill C-338.

As we know, the opioid crisis is impacting communities and families across Canada. My home of British Columbia has been on the coalface, where the addictive use of drugs is now playing Russian roulette. Users never know when they have something in a drug that will kill them.

It does take a multi-pronged approach to tackle this issue. It is a public health emergency, and we continue to ask the Liberal government to recognize it as such. However, it is also important to realize it is a criminal justice issue. This has not been spoken to very well in all the conversations I have heard about this issue.

I will talk a little about how the bill would provide a very important tool, but it is important to first talk about the scope of not just the problem, but the tragedy. We need to also talk about what has been done to date and, more important, what still needs to be done to deal with this issue.

As many are aware, the recent epidemic is characterized by an increasing number of deaths with elicit fentanyl, an opioid substance. Fentanyl was detected back in 2012, when it was in 5% of elicit drugs. By 2016, it was as high as 60%. Fentanyl, carfentanyl, and other drugs are cheap. They are easy to synthesize, and readily available, with a significant volume coming into the country from China. It is being cut into street drugs, with lethal effects.

Carfentanyl, which is a tranquillizer used for elephants, was confirmed on the streets last fall. It is 100 times more potent than fentanyl, 4,000 times more potent than heroin, and 10,000 times more potent than morphine. If anyone has ever had an accident or injury where he or she has received a dose of morphine in the hospital, carfentanyl is 10,000 times more potent. It is coming in by mail order from China. A Calgary man was arrested in September with one kilogram, which could have killed 50 million people.

In B.C. alone, four people have died every day in 2017. It is not any better from 2016. We are on track to go from 900 and some to 1,300 deaths. In one week alone in Vancouver recently, there were 15 deaths. Again, we are averaging four deaths per day. This is just British Columbia, but it is happening across the country.

The people who are dying have many profiles. They might have struggled with addiction for many years or it might just be a young teenager at a party who, for the first time, makes a very bad decision. A recent Facebook post traumatically affected many. A brave mother from Calgary, Sherri Kent, posted a picture of her in a hospital bed with her son Michael just before he died. He was in the intensive care unit, connected to many tubes. There was absolute anguish on her face as she was saying goodbye to him. He had made such a terrible mistake. She did that to raise awareness throughout Canada.

There has been some action to date. Certainly, British Columbia is taking a good lead. Our colleague from Coquitlam—Port Coquitlam introduced the good Samaritan Act, which was recently proclaimed. That was a good step. There is better availability of naloxone, which is used to treat an overdose, although we now hear these drugs have become so potent that people do not respond to it the way they used to.

Bill C-37, which the government put into place, had some good measures in it. However, I continue to have concerns that it moved away from community consultation on safe injection sites. That is an important gap and it is still missing, especially as we now know many of the people who are dying would never use a safe injection site. Although this measure has value in some communities, to take away the ability for community input or to require community input was a bad step.

The banning of the pill presses or importation of designated devices was a good step, as well as some additions to the schedules of substances when there was a reasonable grounds to represent risk.

Most important was the additional power for Canada Border Services to inspect and search packages. We heard that with 30 grams, service agents did not have to inspect. That is absolutely critical because this is coming into the country in an envelope. That is a good measure.

What has been missing in our struggle against this crisis? The federal government. Although the provincial government in British Columbia has asked, the federal government continues to decline in declaring this a state of emergency. The Public Health Agency of Canada should be playing a role in this. There is no good education and awareness campaign. We need the federal government to take on a comprehensive education and awareness campaign.

The next area that has had inadequate services and support is detox and recovery. That is primarily provincial. I know many examples of people who are desperate to get off drugs and turn their lives around. They have found that they do not have any opportunities in the support they need to detox.

We have not talked about the criminals, and my colleague is doing that. These people are knowingly importing and selling drugs on the street, which do kill people. This bill would specifically target gangs and other criminal organizations by introducing tougher sentences for drug traffickers who would exploit the addictions of others for personal profit. Those who import and export these drugs should be brought to justice and should encounter increased mandatory minimums.

I listened to my Liberal colleague. All of a sudden the Liberals have this huge obsession that mandatory minimums are not good. However, mandatory minimums have been around almost as long as the Criminal Code. Probably half of the mandatory minimums were put in place by Liberal governments. For the Liberals to argue that mandatory minimums are always bad and that there are all these issues with mandatory minimums is absolutely ridiculous. They have put many of them in place.

The argument is that mandatory minimums are bad and they do not help. Getting criminals off the street, even if it is for two years, is two years where they are not out there putting fentanyl in drugs that are killing children.

The other thing the Liberals need to be held accountable for is that this is a mandatory minimum of somewhere between two years and life. This is not fettering the discretion of judges. It is saying that parliamentarians believe judges cannot go below two years, that there are no circumstances, ever, where less than two years is an appropriate sentence for someone who is potentially killing our children.

It should be attempted murder. It could go as high as the maximum, jail for life, but, as parliamentarians, we are saying that for those who put fentanyl into drugs and sell them on the streets or bring them in with that purpose should go to jail for two years, at the absolute minimum. For the Liberals and the NDP to say that is not okay is absolutely appalling to me. They need to say that to the mothers and fathers, the families that have lost their children, that they do not think it will help and that they do not want to have a baseline of two years for these people to go to jail.

This is a reasonable bill. Canadians and Parliament have been saying forever that there is baseline for what is acceptable. For people importing drugs, lacing drugs, and selling those drugs on the streets, doing it knowing people can be killed, two years in jail as a mandatory minimum is simply not even enough. The fact that the Liberals and the NDP will not support the bill is absolutely shameful.

[Alistair MacGregor, NDP, Cowichan—Malahat—Langford, BC]

Mr. Speaker, I am pleased to rise today to add my thoughts and voice on Bill C-338. I would like to thank the member for Markham—Unionville for this bill. I know that his intentions are good with respect to this bill and that he, like all members in this House, is concerned about the rash of overdose deaths that are spiking across the country, especially from fentanyl.

Unfortunately, the bill before us does nothing to address the phenomenon of drug use and sees fit only to increase the punishment, through mandatary minimums, for those who are engaged in the import and export of certain substances listed under the Controlled Drugs and Substances Act.

Bill C-338 would amend subsection 6(3) of the Controlled Drugs and Substances Act to punish those who import schedule I or schedule II substances. Schedule I substances include opium, codeine, morphine, cocaine, fentanyl, and of course, the deadly carfentanil, while schedule II is known mainly for cannabis and its derivatives.

Specifically, under paragraph 6(3)(a), the bill would make an amendment so that there would be an increase from a minimum punishment of one year to two years' imprisonment for not more than a kilogram of a schedule I substance or for any amount of a schedule II substance. Under paragraph 6(3)(a.1), the bill would make an amendment so that the minimum punishment was increased from two years' to three years' imprisonment for importing and exporting a schedule I substance that is more than a kilogram.

Increasing mandatory punishments is a favourite legislative pastime of the Conservative party, and this was especially true under the previous Harper government.

The opioid crisis Canada is experiencing is a national emergency that had its origins in my home province of British Columbia. It is a complex phenomenon, a problem the Conservative legacy of supposed tough-on-crime legislation has been ineffective in stemming.

The Supreme Court of Canada has been particularly critical of some of the mandatory minimums, from the previous government, it has struck down. In April 2015, the Supreme Court dealt the Harper government's tough-on-crime agenda a serious blow by striking down a law requiring mandatory minimum sentences for crimes involving prohibited guns. The six-three ruling, penned by the chief justice, took aim at the government's keeping-Canadians-safe justification for tough sentencing laws. In her ruling, she said,

The government has not established that mandatory minimum terms of imprisonment act as a deterrent against gun-related crimes.... Empirical evidence suggests that mandatory minimum sentences do not, in fact, deter crimes....

In April 2016, the court ruled six-three that a mandatory minimum sentence of one year in prison for a drug offence violates the Charter of Rights and Freedoms. The court ruled that the sentence cast too wide a net over a wide range of potential conduct and stated in its ruling:

If Parliament hopes to maintain mandatory minimum sentences for offences that cast a wide net, it should consider narrowing their reach so that they only catch offenders that merit that mandatory minimum sentences. In the alternative, Parliament could provide for judicial discretion to allow for a lesser sentence where the mandatory minimum would be grossly disproportionate and would constitute cruel and unusual punishment.

Bill C-338 stems from a belief that we can arrest and incarcerate our way out of the problem of drugs in our society. However, if we look at the facts, they show otherwise. Police-reported drug offences in 2014, after the Conservative tough-on-crime legislation from the year before, showed that meth possession went up 38%, heroin possession went up 34%, MDMA possession increased by 28%, meth trafficking went up by 17%, and heroin trafficking went up by 12%. It is clear that the Conservative agenda on mandatory minimums for drug crimes has not decreased drug use across the country, and it is evident that we need effective solutions now.

The Conservatives recently copied the NDP's call to declare the opioid overdose crisis a national health emergency, yet the Conservatives blocked our attempt to move Bill C-37 swiftly through the House in December, which would have saved lives faster.

If we look at some of the main points in Bill C-37, it would simplify the process of applying for an exemption that would allow for supervised consumption, which has been shown to help people take care of their issues. It would have prohibited the importation of designated devices, which are used in manufacturing drugs. It would have expanded “the offence of possession, production, sale, or importation of anything knowing that it would be used to produce or traffic in methamphetamine”. These were clear-cut solutions to a problem our province has been long suffering through and that is now making its way across Canada.

I would like to read some quotes from validators of our position.

Dr. Virani, who is a medical director at Metro City Medical Clinic, in Edmonton, said:

I have yet to meet a police officer who has said they can arrest their way out of this problem, and I have yet to meet a judge who's said that he can incarcerate his way out of the problem, and I certainly hope that health isn't thinking [they can] ignore-and-wait their way out of this problem, because it is clear it is getting worse and worse.

British Columbia's provincial health officer, Dr. Perry Kendall, said:

Simply prohibiting and increasing penalties without resources to support and educate haven't been terribly effective. [But] you need to do a number of things to limit the supply of drugs on the street.

I am disappointed and frustrated that the Liberals' promise of a review of mandatory minimums is not complete. It was last year that the Supreme Court handed down its decision on the Jordan case, which was in response to decades of inadequate resources for our justice system from successive federal and provincial governments. We now have a situation where serious criminal charges are either being stayed or withdrawn.

While I appreciate that the Minister of Justice has recently met with her provincial counterparts, I sincerely hope that the review of mandatory minimums is completed soon and in a comprehensive way so that we do not have a continued piecemeal approach to justice legislation created by private members' bills, like the one before us today.

Canada is currently experiencing an unprecedented opioid overdose crisis. Illicit drug overdoses claimed the lives of 914 people in B.C. alone in 2016, making it the deadliest overdose year on record and representing an increase of nearly 80% from the year before.

A significant spike in drug-related overdoses in 2016 prompted B.C.'s provincial health officer, Dr. Perry Kendall, to declare a public health emergency for the first time in the province's history.

Under the Harper government's anti-drug strategy, $190 million was budgeted for treatment alone in the first five years of the strategy, from 2007 to 2012, but only $77.9 million was actually spent. The total treatment budget for the next five years of the strategy was cut to $150 million. However, this represents $40 million more than the Liberal budget has allocated for its entire Canadian drugs and substances strategy. How much longer do we have to wait for the current government?

I will now move on to my conclusion. We need real measures that deal with the problem of drugs, rather than tying judges' hands in sentencing laws in order to appear tough. A sentencing judge should retain the discretion to sentence within the limits set by Parliament. Judges must be able to weigh all the evidence and decide on a fair sentence that fits the crime. Mandatory minimums take away judges' ability to do just that.

I sincerely fail to see how increasing jail time by a year for those who import or export schedule I or schedule II substances is in any way going to contribute to a meaningful reduction in drug use in our country. It is for that reason I will be voting against Bill C-338.

We need the federal government to take leadership on the opioid crisis now. Mayors and premiers have been asking for help dealing with drug overdoses. It is time that we all work together to bring forth effective policies to tackle this national crisis.

[Bill Blair, Liberal, Parliamentary Secretary to the Minister of Justice and Attorney General of Canada]

Mr. Speaker, I am pleased to have the opportunity to discuss this morning, Bill C-338, an act to amend the Controlled Drugs and Substances Act, which proposes to increase mandatory minimum penalties and imprisonment for the importation and exportation of certain drugs.

The objective of Bill C-338 is to target the importation and exportation of powerful opiates such as fentanyl in Canadian communities, an objective that everyone in the House would agree is laudable. The bill proposes to denounce the importation and exportation of these lethal drugs by increasing the mandatory minimum penalty from one to two years where the quantity of these drugs is less than one kilogram and certain aggravating factors are present. In other cases, the mandatory minimum penalty would be increased from two to three years. The bill also proposes to increase the mandatory minimum penalty from one to two years for the importation or exportation of any amount of a schedule II drug, namely cannabis.

As has been already articulated in the House this morning, we find ourselves in the midst of a national health crisis, and this has put the spotlight on the importance of comprehensive and evidence-based Canadian drug policies.

Canadian communities are feeling the devastating impact from the growing number of opioid-related deaths and overdoses. Canadians deserve nothing less than concerted government action that would have an immediate impact on addressing the influx of opioids in our communities. The policies put in place to respond to this crisis must be informed by performance measurement standards and evidence. These policies must have an immediate impact on reducing the number of these tragic deaths.

This is why I am happy to see that the Government of Canada has instituted a modernized Canadian drugs and substances strategy. The Canadian drugs and substances strategy is focused on prevention, treatment, and enforcement, but it also reinstates harm reduction as a core pillar of Canada's drug policy. The CDSS champions a comprehensive, collaborative, compassionate, and evidence-based approach to drug policy.

In furtherance of this strategy, the Minister of Health introduced Bill C-37, an act to amend the Controlled Drugs and Substances Act and to make related amendments to other acts, to address the serious and pressing public health issues related to opioids. This legislative response is one important part of the government's comprehensive approach to drug policy in Canada.

Bill C-37 proposes, first, to simplify and streamline the application process for supervised consumption sites; second, to clamp down on illegal pill presses; and, third, to extend the authority of border officers to inspect suspicious small packages coming into Canada. In relation to the last point, extending the Canada Border Services Agency's inspection powers is important, because one standard-size envelope can contain 30 grams of fentanyl, potent enough to cause 15,000 overdoses. These numbers increase exponentially where the substance in question is carfentanil.

In addition, the government has invested over $65 million over five years to support the new CDSS and implement its five-point opioid action plan. This amount is in addition to the $10 million in emergency support that the federal government has provided to the Province of British Columbia to assist in its response to overwhelming numbers of overdose and opioid-related deaths in that province. The five-point opioid action plan is focused on increasing public awareness, supporting better prescribing practices, reducing access to opioids in appropriate cases, supporting better treatment options for patients, and improving Canada's data collection and evidence base to inform more effective drug policies in the future.

That is not all that the government of Canada is doing. Canada is also working closely in collaboration with our international partners, such as the United States and China, to address this crisis. Senior law enforcement and border officials are already working together on a regular basis to curb the flow of illegal opioids across international borders, and I will cite an example. The Royal Canadian Mounted Police has reached an agreement with China's Ministry of Public Security to enhance operational collaboration, identify key areas of concern, and work towards a more coordinated approach to combat fentanyl trafficking originating from China. Such partnerships are a testament to the reality that this epidemic is a very serious international problem which will require international co-operation to fix. Addressing the roots of the opioid crisis demands a whole-of-society response.

This brings us to Bill C-338. Although its stated objective is both timely and I am certain well intentioned, the proposed increase to mandatory minimum penalties is neither likely to contribute to deterring offenders from importing and exporting powerful opiates, nor to have any impact on addressing opioid-related deaths across Canada.

I am not aware of any evidence suggesting that increased mandatory minimum penalties would be effective in reducing the importation or exportation of these lethal drugs, including opiates, into Canada.

Although deterrence is a frequently cited argument of supporters of mandatory minimum penalties, my understanding is that the vast majority of the research in this area shows that these mandatory minimum penalties are ineffective in deterring crime. In fact, the likelihood of being caught represents the far greater deterrent.

In addition to the fact that increasing mandatory minimum penalties would not likely have a meaningful impact on lowering the number of opioid-related deaths in Canada, Bill C-338's proposal to increase mandatory minimum penalties would have a number of adverse effects on the proper administration of the criminal justice system, all of which have been well documented here in Canada and abroad. I am aware of several studies that suggest that mandatory minimum penalties actually lead to far fewer guilty pleas, increased litigation, and an increase in the time required to complete cases.

Given the Supreme Court of Canada's recent decision in Regina v. Jordan, we must be mindful of policies that contribute to excessive delays, which plague our criminal justice system. In fact, last month, when federal, provincial, and territorial ministers responsible for justice met to discuss priority responses to further reduce delays in the criminal justice system, they unanimously identified mandatory minimum penalties as one area of legislative reform that could help in improving court delays. International research also reveals that the use of mandatory minimum penalties to combat the war on drugs in the United States has resulted in far higher costs associated with the dramatic increase in litigation and the use of imprisonment.

I am also concerned about the charter risks associated with increasing mandatory minimum penalties. I am aware of two recent Supreme Court of Canada decisions that clearly state that mandatory minimum penalties that apply to offences that can be committed in various ways under a broad array of circumstances and by a wide range of people are constitutionally vulnerable. Based on these rulings, I am concerned that the mandatory minimum penalties proposed in this bill are vulnerable, because they could apply to offenders who have committed a crime for which the proposed mandatory minimum penalty would be unjust.

Bill C-338's increased mandatory minimum penalties are not necessary to signal to Canadian judges that these offences should be treated seriously. Canadian judges, in appropriate cases, already exercise their discretion to impose significantly higher sentences in excess of the proposed mandatory minimum penalties. For example, in Regina v. Cunningham, the Court of Appeal for Ontario confirmed that the appropriate sentencing range for first-offender drug couriers who smuggle large quantities of cocaine should be in the range of six to eight years' imprisonment. In that decision, the court, mindful that many drug couriers are easy prey for commercial drug traffickers, noted that such concerns must give way to the need to protect society from the untold grief and misery occasioned by the illicit use of hard drugs. In fact, it increased a three-year sentence imposed to five years' imprisonment and stated clearly that it is the responsibility of the courts to warn would-be couriers, in no uncertain terms, that they will pay a heavy price for choosing to import large quantities of hard drugs for quick, personal gain.

More recently, the British Columbia Court of Appeal, in Regina v. Smith, noted that given the development of a public health crisis surrounding opioids, a higher sentencing range was appropriate for certain trafficking offences under the Controlled Drugs and Substances Act.

I am confident that the courts will impose just sentences based on the facts before them. On the whole, I believe that the approach advanced by the government is the right one. Changes to increase mandatory minimum penalties may seem on their face attractive, but they simply will not work to address the public health emergency. For all the reasons I have noted, the government will not support Bill C-338.

[Alistair MacGregor, NDP, Cowichan—Malahat—Langford, BC]

Mr. Speaker, as a resident of British Columbia, specifically on Vancouver Island, I need only look across the water to see how bad the fentanyl crisis is in Vancouver.

Indeed, and I direct my comments to the government side, if we had an infectious disease killing at the rate that overdoses are in British Columbia, the government would have mobilized far more resources and in a much quicker time frame than has been done.

I am glad to see that the Conservatives recently joined us to declare the opioid crisis a national health emergency, but when we attempted to move Bill C-37 through the House quickly to deal with the problem, Conservatives attempted to block it. I am just wondering what the member's reasoning was for that blocking.

[Simon Kennedy]

There's a lot of work on opioids under way in the health portfolio right now. I could give you a catalogue of the areas that we're working on, the priorities.

With regard to the money in the budget, the government has not to date come out and publicly said this is the specific breakdown of how the new funds will be spent, but my understanding is that will be happening shortly. I wouldn't want to pre-empt the minister or the government in that regard.

Some areas are priorities for us. For example, we have laboratories across the country that do analysis of drug samples seized in raids by the police and that sort of thing. Obviously, because of the rise of synthetic opioids, the demand for those laboratory services has gone up significantly. The provinces have asked for additional assistance from our laboratories. So one area of priority for us going forward with some of the resources we received is going to be a substantial increase in the ability of our labs to respond to the opioid crisis, as well as an ability to analyze substances more quickly, and perhaps more public reporting, better assistance to provinces, and so on. That would be one example.

When Bill C-37 goes through, we want to be able to more expeditiously process requests for things like supervised consumption facilities. That's an area we want to beef up.

We have been doing a lot of work on the regulatory side to try to support provinces in enabling access to new therapies as an example. That's another area that we've been prioritizing.

I know the Public Health Agency has been doing a lot of work as well. I'm sure it could speak to some of the things it's doing. There's a long catalogue of initiatives we're working on. We would use the new resources to support those kinds of activities.

[Jane Philpott, Liberal, Markham—Stouffville, ON]

The circumstances are a sobering reality, and Mr. Davies has highlighted some of what's actually happening. I think we are seeing good progress

However, this is a crisis that has been bubbling up for some time. To manage people's expectations, while I would like to be able to say it's going to turn around immediately, we have to realize that it's taken years to get to where we are and it's going to take some time to turn this around. I am pleased with the progress that's been made.

You asked specifically around Bill C-37, and I once again want to reiterate my thanks to this committee for your expeditious work on that. You had already studied the matter and were able to move it through. We look forward to the passage of that bill, and I hope it will be very soon. I met with the Senate committee last week, and they are still taking hearings, but I hope we will see that moved through very quickly.

A few weeks ago, I was able to announce three new supervised consumption sites in Montreal that were working under the previous legislation, but it had taken them 18 months in the application process to get to that point. We now have another 11 sites in the queue. If we can get that bill through quickly, that really changes the landscape in terms of what it requires, not only for those who are in the queue but for others who will come after them. We hope to be able to announce new sites in the future.

Also, I want to once again remind the committee that while access to supervised consumption sites in communities that want and need them will be effective in saving lives and reducing suffering associated with substance use, this is one of a whole range of measures. We always need to keep our eye on the comprehensive response to this crisis.

[John Oliver, Liberal, Oakville, ON]

Thank you very much, Mr. Chair, and thank you very much for the leadership you've been providing for a very important file for all Canadians. It's great to have you as our Minister of Health.

My first question is around the opioid crisis that we've been dealing with, and fentanyl. It is wonderful in Bill C-37 to see a return to evidence-based harm reduction approaches to this crisis, which is a big change from what we had in place before. So with Bill C-37 coming forward, can you tell the committee, are we seeing easier access to safe consumption sites, and are we starting to see prescription changes in naloxone availability? Are you sensing a turn here?

[Jane Philpott, Liberal, Minister of Health]

Thank you, Mr. Chair.

I appreciate being invited here today to discuss Health Canada's 2017-18 main estimates and our proposed spending, which has been identified as part of budget 2017.

Since I was here last year presenting the main estimates, I've had the opportunity to travel the country, and to visit and hear from Canadians about the health issues that concern them. I know that you, as a committee, have also heard from many Canadians, including those in indigenous communities in this country.

My career as a medical doctor made me realize how necessary it is to improve health outcomes for Canadians. My experiences as a minister over the past year have confirmed that.

I'm very pleased to have this opportunity to discuss the resources that we, as a federal government, are putting towards making these kinds of improvements.

Thank you, Mr. Chair, for announcing those who are accompanying me today. I will not repeat their names. I'm pleased that they are here.

I will first say a few words, and then I would be pleased to answer your questions.

As you'll see reflected in the 2017-18 main estimates, Health Canada is delivering on many priority initiatives for our government. These are going to result in approximately $4 billion in spending authorities for 2017-18. This is a net increase of more than $500 million from 2016-17, and there will be significant additional investments that were outlined in budget 2017 and will be identified through future supplementary and main estimates exercises.

I would like to highlight some of our government's priorities and the actions my department is taking to address them.

Canada's publicly funded health care system, as you well know, is a great source of pride for Canadians. The federal government along with our provincial and territorial partners recognize the need to strengthen the health care system so that it adapts, innovates, and addresses the many new challenges that Canadians are facing every day.

I'm pleased that almost all jurisdictions now have accepted our federal offer of new investments in health care with significant new money, in particular for shared priorities including mental health and home care.

You will note that over the next five years, the Canada health transfer amounts provided to provinces and territories are expected to total approximately $200 billion, providing long-term, predictable, and growing funding to our provincial and territorial partners.

This year's funding, for example, will be approximately $1.1 billion higher than it was last year.

As part of our deliberations with the provinces and territories, we identified some particular health care priorities, specifically, mental health and home care.

One thing I learned as a doctor, and no doubt you all understand as well, is that there is no health without mental health.

Over the past few months, I have had meetings in eastern Canada and I participated in a roundtable in Toronto. Stakeholders talked to me about what we could do to improve mental health services, especially when it comes to young people, and the need to monitor those improvements.

There's a growing awareness in Canada about both the importance of mental health and the large number of Canadians who are affected by it. Indeed, most Canadians are affected, either directly or indirectly, by matters of mental illness.

There's a recognition, as well, about the tremendous importance of and the rising need for home care. As we may have discussed before, some 15% of hospital beds are currently occupied by patients who would prefer to receive their care at home or who would be better off in some kind of community-based setting.

Budget 2017 proposes to provide $6 billion over 10 years for home care and $5 billion over 10 years to support better access to mental health care. These initiatives will make Canada's health care systems more responsive to the needs and expectations of all Canadians.

Two other priorities were identified during discussions leading to a renewed health accord—making prescription drugs more affordable and ensuring that our health care is more focused on innovation.

To improve access to prescription medicines and lower drug prices, budget 2017 proposes to invest $140 million over the next five years. This will support important work by Health Canada, the Patented Medicine Prices Review Board, and the Canadian Agency for Drugs and Technologies in Health. To expand e-prescribing, virtual care initiatives, and the adoption and use of electronic medical records, we propose $300 million over the next five years to support the Canada Health Infoway.

We also propose to invest $51 million over three years in the Canadian Foundation for Healthcare Improvement, to help accelerate innovation in our health care system. We plan to invest $53 million over the next five years for the Canadian Institute for Health Information to improve decision-making and strengthen reporting of health-related principles and outcomes.

Based on observations from my own travels to first nations and Inuit communities across the country, I believe very strongly that improving the health of indigenous peoples in Canada must be a priority for our government.

The Truth and Reconciliation Commission of Canada has asked the federal government to close the gaps in health outcomes between aboriginal communities and non-aboriginal communities. That is exactly what we are currently doing.

Through budget 2017, we're proposing to invest $813 million in new money for health services for first nations and Inuit. This includes new money to increase community-based infectious disease programming, to expand access to nurse practitioners as well as physician services, to increase access to mental health and wellness services, and to increase home and community care services on reserve.

As you'll note in the main estimates, Health Canada's funding for first nations and Inuit health programs will increase by approximately $440 million this year. This will include $82 million for major repairs, expansions, and new construction of health infrastructure such as nursing stations, health centres, acute care facilities, as well as drug and alcohol treatment centres.

The estimates also include support for three other related matters: $58 million to continue implementing our legal obligations under the Indian Residential Schools Settlement Agreement; $27 million to provide first nations communities on reserve with access to safe, reliable water and waste-water systems; and $25 million to address urgent mental health needs in these communities.

Finally, we will also invest this year $137 million in interim reforms related to Jordan's principle. This will ensure that first nations children on reserve have access to the same publicly funded health and social services as other Canadians, and that no child falls through the cracks. The need for this action is obvious. In July 2016, we announced funding of $382 million over three years. Since then, more than 3,300 requests for services and supports related to Jordan's principle have been approved for first nations children.

Another health priority we're addressing is our country's opioid crisis.

I went to British Columbia and met with those who have to deal with the crisis—first responders who are repeatedly called upon to deal with overdoses, as well as families and friends who are suffering the loss of a loved one.

I also want to thank the committee for the work it has done thus far, especially its effort to accelerate the passing of Bill C-37 by Parliament.

Addiction rates and overdose rates are on the rise, and our response must be comprehensive, collaborative, compassionate, and evidence-based.

Last December, I announced the Canadian drugs and substances strategy, which will replace the current national anti-drug strategy. It re-establishes harm reduction as one of the key pillars of our policy along with prevention, treatment and law enforcement.

In February of this year, we announced $65 million over five years for national measures to respond to the crisis, and budget 2017 proposes an additional $35 million, for a total of new investments of more than $100 million over the next five years.

Our government is well on track toward legalizing, strictly regulating, and restricting access to cannabis.

On the matter of CFIA, the health of Canadian families depends on access to safe and nutritious foods. To help strengthen Canada's world-class food safety system, budget 2016, you'll recall, provided $38.5 million over two years to invest in systems that focus on high-risk domestic and imported foods. Budget 2017 continues this direction, proposing to provide up to $149 million over the next five years to the Canadian Food Inspection Agency to carry out this work.

That funding enables the CFIA to develop more stringent and consistent food safety regulations, and to modernize core food safety inspection programs. As a result, Canada will be better able to prevent, identify and address food safety risks.

In addition, several of the priorities of budget 2017 will require that agencies across the health portfolio continue to collaborate on many health priorities. For example, budget 2017 proposes to allocate $47 million over five years to Health Canada, the Public Health Agency of Canada, and the Canadian Institutes of Health Research to develop and implement a national action plan to address the broad range of health risks associated with climate change.

I am confident that the amounts noted in our main estimates and the funds identified in budget 2017 are going to help us to continue to support better health outcomes for all Canadians and to build a healthier country.

Thank you to the committee once again for inviting us to join you today. We are grateful for your contributions. I am certainly looking forward to your questions.